Kovack Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Kovack Advisors's RPRX Position: Q3 2026 in Review
Kovack Advisors opened a new position in Royalty Pharma (RPRX) in Q3 2026: 609 shares worth $35.1K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings.
705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Kovack Advisors held 609 shares of Royalty Pharma worth $35.1K as of Q3 2026.
- Royalty Pharma was a new Kovack Advisors position in Q3 2026.
- Royalty Pharma made up ﹤0.01% of Kovack Advisors's portfolio in Q3 2026, its #1091 holding.
- 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.